Korro Bio Inc (KRRO)
50.13
-4.88
(-8.87%)
USD |
NASDAQ |
Nov 14, 16:00
49.37
-0.76
(-1.52%)
After-Hours: 20:00
Korro Bio Net Income (Quarterly): -21.83M for June 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | -21.83M |
March 31, 2024 | -19.56M |
Date | Value |
---|---|
June 30, 2023 | -17.65M |
March 31, 2023 | -19.60M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-21.83M
Minimum
Jun 2024
-17.65M
Maximum
Jun 2023
-19.66M
Average
-19.58M
Median
Net Income (Quarterly) Benchmarks
Marker Therapeutics Inc | -2.193M |
Pliant Therapeutics Inc | -57.76M |
CEL-SCI Corp | -6.857M |
AIM ImmunoTech Inc | -1.836M |
IGC Pharma Inc | -2.378M |
Net Income (Quarterly) Related Metrics
Total Expenses (Quarterly) | 24.12M |
EPS Diluted (Quarterly) | -2.43 |
Enterprise Value | 354.09M |
Earnings Yield | -19.00% |